Evidence-based recommendations on dostarlimab (Jemperli) with platinum-containing chemotherapy for primary advanced or recurrent endometrial cancer with microsatellite stability or mismatch repair ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback